Yemenite deaf-blind hypopigmentation syndrome
(Redirected from Warburg–Thomsen syndrome)
Yemenite deaf-blind hypopigmentation syndrome is a condition caused by a mutation on the SRY-related HMG-box gene 10[2] (not SOX10).[3]
| Yemenite deaf-blind hypopigmentation syndrome | |
|---|---|
| Other names | Warburg-Thomsen syndrome[1] |
It was characterized in 1990,[4] after being seen in two siblings from Yemen who presented with a "hitherto undescribed association of microcornea, colobomata of the iris and choroidea, nystagmus, severe early hearing loss, and patchy hypo- and hyperpigmentation."[1] Some sources affirm SOX10 involvement.[5][6]
See also
editReferences
edit- ^ a b Lurie, Iosif W. & Victor A. McKusick (17 March 1997). "Yemenite deaf-blind hypopigmentation syndrome". Online Mendelian Inheritance in Man. Johns Hopkins University. Retrieved 25 January 2014.
- ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. p. 717. ISBN 978-1-4160-2999-1.
- ^ Bondurand N, Kuhlbrodt K, Pingault V, et al. (September 1999). "A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies". Hum. Mol. Genet. 8 (9): 1785–9. doi:10.1093/hmg/8.9.1785. PMID 10441344.
- ^ Warburg M, Tommerup N, Vestermark S, et al. (September 1990). "The Yemenite deaf-blind hypopigmentation syndrome. A new oculo-dermato-auditory syndrome". Ophthalmic Paediatr Genet. 11 (3): 201–7. doi:10.3109/13816819009020980. PMID 2280978.
- ^ Lang D, Epstein JA (April 2003). "Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer". Hum. Mol. Genet. 12 (8): 937–45. doi:10.1093/hmg/ddg107. PMID 12668617.
- ^ Alexander M. Holschneider; Prem Puri (13 December 2007). Hirschsprung's Disease and Allied Disorders. シュプリンガー・ジャパン株式会社. pp. 124–. ISBN 978-3-540-33934-2. Retrieved 2 January 2011.
External links
edit
 | This cutaneous condition article is a stub. You can help Wikipedia by expanding it. |